Page last updated: 2024-08-16

triazolam and methylphenidate

triazolam has been researched along with methylphenidate in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19902 (14.29)18.7374
1990's2 (14.29)18.2507
2000's6 (42.86)29.6817
2010's4 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Honda, H; Okuma, T1
Iwata, T; Kayukawa, Y; Ohta, T; Okada, T1
Itoh, A; Iwata, T; Kasahara, Y; Ohta, T; Okada, T; Ozaki, N1
Kollins, SH; Pazzaglia, PJ; Rush, CR1
Baker, RW; Rush, CR1
Glaser, PE; Lile, JA; Rush, CR; Stoops, WW1
Hays, LR; Kelly, TH; Lile, JA; Pinsky, DJ1
Hays, LR; Rush, CR; Sevak, RJ; Stoops, WW1
Hays, LR; Kelly, TH; Lile, JA1

Reviews

1 review(s) available for triazolam and methylphenidate

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

5 trial(s) available for triazolam and methylphenidate

ArticleYear
Model insomnia, noise, and methylphenidate, used for the evaluation of hypnotic drugs.
    Psychopharmacology, 1978, Apr-28, Volume: 57, Issue:2

    Topics: Adult; Drug Evaluation; Electroencephalography; Flurazepam; Humans; Hypnotics and Sedatives; Male; Methylphenidate; Noise; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep, REM; Time Factors; Triazolam

1978
Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
    Experimental and clinical psychopharmacology, 1998, Volume: 6, Issue:1

    Topics: Adult; Affect; Blood Pressure; Bupropion; Dextroamphetamine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Female; GABA Modulators; Heart Rate; Humans; Male; Methylphenidate; Middle Aged; Psychomotor Performance; Triazolam

1998
Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.
    Experimental and clinical psychopharmacology, 2001, Volume: 9, Issue:1

    Topics: Adult; Behavior; Blood Pressure; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Discrimination, Psychological; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Hypnotics and Sedatives; Male; Methylphenidate; Middle Aged; Psychomotor Performance; Surveys and Questionnaires; Triazolam

2001
Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Experimental and clinical psychopharmacology, 2005, Volume: 13, Issue:1

    Topics: Adult; Central Nervous System Stimulants; Dextroamphetamine; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Hypnotics and Sedatives; Male; Methylphenidate; Psychomotor Performance; Surveys and Questionnaires; Triazolam

2005
The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users.
    Behavioural pharmacology, 2010, Volume: 21, Issue:1

    Topics: Adult; Analgesics, Opioid; Blood Pressure; Body Temperature; Choice Behavior; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dronabinol; Drug Users; Female; GABA Modulators; Heart Rate; Humans; Hydromorphone; Male; Marijuana Smoking; Methylphenidate; Psychomotor Performance; Reinforcement, Psychology; Respiration; Skin Temperature; Triazolam

2010

Other Studies

8 other study(ies) available for triazolam and methylphenidate

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Daily activity and persistent sleep-wake schedule disorders.
    Progress in neuro-psychopharmacology & biological psychiatry, 1992, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Aging; Amides; Body Temperature; Circadian Rhythm; Female; Humans; Hydroxybutyrates; Male; Methylphenidate; Sleep; Sleep Stages; Sleep Wake Disorders; Triazolam; Vitamin B 12

1992
A treatment trial of delayed sleep phase syndrome with triazolam.
    The Japanese journal of psychiatry and neurology, 1989, Volume: 43, Issue:1

    Topics: Adult; Arousal; Circadian Rhythm; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazolam

1989
Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.
    Psychopharmacology, 2009, Volume: 203, Issue:2

    Topics: Administration, Oral; Adult; Case-Control Studies; Discrimination, Psychological; Double-Blind Method; Dronabinol; Female; Humans; Hydromorphone; Male; Marijuana Abuse; Methylphenidate; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Surveys and Questionnaires; Triazolam; Young Adult

2009
Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 328, Issue:3

    Topics: Anti-Anxiety Agents; Central Nervous System Stimulants; Dextroamphetamine; Diastole; Discrimination, Psychological; Heart Rate; Humans; Hypnotics and Sedatives; Methamphetamine; Methylphenidate; Reward; Sensitivity and Specificity; Surveys and Questionnaires; Systole; Triazolam; Young Adult

2009